W3C Forms Life Science Semantic Web Group


By Salvatore Salamone Bio-IT World

The World Wide Web Consortium (W3C) today announced the formation of a new group that seeks to bring life scientists and Semantic Web experts together to help improve the way data is accessed, shared, and analyzed.

Specifically, the Semantic Web Health Care and Life Sciences Interest Group (HCLSIG) aims to help life scientists tap the potential benefits of using Semantic Web technology by developing use cases and applying standard Semantic Web specifications to healthcare and life sciences problems.

This application of standards to a specific community is a W3C first. The W3C sees it as a way to help push the adoption of Semantic Web technology in general. 

“This new venture puts W3C specifications through the paces of a dynamic, multifaceted, and interdependent set of communities,” said Tim Berners-Lee, W3C director. “We have a remarkable opportunity to listen to the area experts, to see how our work meets their needs, and to serve their future requirements.”

Overseeing the HCLSIG for the W3C will be Eric Miller, Semantic Web activity lead, W3C, who will look to industry to provide the oversight needed to bring in the subject matter expertise. To that end, he has recruited co-chairs Eric Neumann (an independent consultant and former global head of knowledge management at Aventis, which was acquired by Sanofi and became Sanofi-Aventis) from the life sciences and Tonya Hongsermeier, corporate manager, clinical knowledge management and decision support at Partners HealthCare System from healthcare.

Miller notes the origin of the group goes back to a gathering about a year ago. “When we brought together people in the Semantic Web Life Sciences Workshop it was exciting to see the benefits [that Semantic Web might bring to] the problems and issues they were dealing with,” said Miller. That workshop included researchers and IT professionals from many pharmaceutical companies, academic labs, and other life science organizations. (For a summary of that workshop go here.)

At that point it became clear to both the W3C and life scientists that it made sense for the two groups to work together.

The HCLSIG will operate within the W3C as an active group where vendors, users, and industry professionals will come together in vendor-independent way to address issues facing the industry.

One role of the HCLSIG will be to develop use cases that illustrate the value of adopting Semantic Web technology, core vocabularies, and ontologies. To accomplish this, Miller sees the group providing a forum that supports communication, education, and collaboration. “The W3C has a strong track record of sharing use cases,” said Miller.

While the HCLSIG will focus on specific issues related to the life sciences and healthcare, related W3C work in broader applications areas (such as security) will also be taken into account. Additionally, the group will work with other Semantic Web groups.

One area where the group will likely apply its efforts is to finding ways to make existing life science and healthcare vocabularies and ontologies work within a Semantic Web context. Making existing data Semantic Web-aware will make it easier to access, find, and share that information. And once the information is in a Semantic Web format, “people will start seeing the benefits as they will be able to stitch together data,” said Miller.

The group’s website already has a collection of several well known and some lesser known life sciences Semantic Web examples. Examples include BioDash, active semantic electronic medical records, and Partners’ Health Care Knowledge Management Portal. More will be added over time.

To coincide with the group’s announcement, the HCLSIG also put out a call for participation in its first formal meeting. The event will be held January 25th and 26th in Boston. Details about the meeting can be found here. “We hope to have people fly in from all over the world,” said Miller.

Related Stories:

Masters of the Semantic Web

Getting the Gobbledygook Out of Data Sharing

Berners-Lee Seeks Killer App for Semantic Web

The Key to the Semantic Web

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.